Balanced news tone
News Sentiment
GSS sentiment intelligence
Genetic Signatures Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
84/100 classification confidence.
directly relevant articles
high-authority source matches
-5.9% over one week, -13.5% over four weeks, trend inactive, and below fair value.
Enterprise value to revenue forward of Genetic Signatures Ltd. – ASX:GSS
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Enterprise value to revenue forward of Genetic Signatures Ltd. – ASX:GSS
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jul 2026 13:14
- Source
- TradingView
Genetic Signatures (ASX: GSS) Bounces 8% But Remains a Major Loser Over the Year: Is the Molecular Diagnostics Company Near a Floor?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 13:20
- Source
- Kalkine
BCAL Diagnostics Crosses 10% Threshold in Genetic Signatures with $1.39 Million Share Purchase
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- Kalkine
BCAL takes stake in Genetic Signatures to broaden diagnostics capabilities
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 02 Jul 2026 01:19
- Source
- BiotechDispatch
Perennial Value Management Lifts Stake in Genetic Signatures to 14.81% Through On-Market Trades
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 18 Jun 2026 07:00
- Source
- Kalkine
Genetic Signatures (ASX:GSS) Collapses 39% on Wednesday — What Investors Need to Know About Q3 Update
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Apr 2026 07:00
- Source
- Kalkine
Genetic Signatures (ASX: GSS) Rebounds Amid International Expansion Signals
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Apr 2026 07:00
- Source
- Kalkine
ASX Runners of the Week: Bison, Genetic Signatures, Narryer & Immutep
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Apr 2026 07:00
- Source
- The West Australian
Why Genetic Signatures (ASX:GSS) Is Up 22% on Wednesday?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Apr 2026 07:00
- Source
- Kalkine
Genetic Signatures reshapes its business to cut costs and drive growth
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Mar 2026 07:00
- Source
- BiotechDispatch
Slammed 26% Genetic Signatures Limited (ASX:GSS) Screens Well Here But There Might Be A Catch
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jan 2026 08:00
- Source
- simplywall.st
We're Not Very Worried About Genetic Signatures' (ASX:GSS) Cash Burn Rate
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 15 Jan 2026 08:00
- Source
- simplywall.st
Here's Why We're Not Too Worried About Genetic Signatures' (ASX:GSS) Cash Burn Situation
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 10 Jan 2026 08:00
- Source
- Market source
Insights: Genetic Signatures Ltd (ASX:GSS)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Oct 2025 17:38
- Source
- smallcaps.com.au
Genetic Signatures (ASX: GSS) Soars 47% on Record Quarterly Sales
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 21 Oct 2025 07:00
- Source
- Stocks Down Under
Genetic Signatures launching GI parasite test in US following clearance
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jun 2024 07:00
- Source
- BioWorld News